Epsilon M&A Deal Report - Institut Génétique Nantes Atlantique (IGNA)
Transaction Multiples for the Valuation of Private Companies
Carso / Institut Génétique Nantes Atlantique (IGNA)
No EMAT :
19652
Announced Date :
22/09/2008
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Carso
Target :
Institut Génétique Nantes Atlantique (IGNA)
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Institut Genetique Nantes Atlantique (IGNA) is a DNA forensic laboratory that carries out genetic fingerprinting analyses for judicial enquiries in criminal cases and establishes DNA profiles for...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | |||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
| Date | Acquirer | Target | Country | Multiples | See details |
| 27/03/2008 | Synexel Research International | French laboratory of Parexel International | France | * | 19649 |
| 09/04/2003 | Pharma Services Holding | Quintiles Transnational | United States | ** | 19640 |
Source: Epsilon Research / EMAT
